Pharmaceutical thrombosis prophylaxis, bleeding complications and thromboembolism in a national cohort of hysterectomy for benign disease

Human Reproduction

Volumn 27, Issue 6, 2012, Pages 1628-1636

  Brummer, T H I ^a   Heikkinen, A ^b   Jalkanen, J ^c   Fraser, J ^d   Makinen J ^e   Tomas E ^f   Sepapal T ^g   Sjoberg J ^a   Harkki P ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Central Finland Central Hospital   (Finland)

^d NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

^g AALTO UNIVERSITY   (Finland)

Author keywords

Benign disease; Hysterectomy; Low molecular weight heparin; Pharmaceutical thrombosis prophylaxis; Venous thromboembolic events

Indexed keywords

DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; FEMALE; FINLAND; GROUPS BY AGE; HEMATOMA; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATIONAL STUDY; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RISK FACTOR; SURGICAL APPROACH; THROMBOSIS PREVENTION; TREATMENT INDICATION; UTERUS PROLAPSE; VAGINAL HYSTERECTOMY; VENOUS THROMBOEMBOLISM;

EID: 84861541119     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des103     Document Type: Article

References (39)

1. ACOG Practice Bulletin 84. Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007;110:429-440.
2. Ageno W, Manfredi E, Dentali F, Silingardi M, Ghezzi F, Camporese G, Bolis P, Venco A. The incidence of venous thromboembolism following gynecologic laparoscopy: a multicenter, prospective cohort study. J Thromb Haemost 2007;5:503-506.
3. Ballard R, Bradley-Watson P, Johnstone F, Kenney A, McCarthy T. Low-doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecological surgery. J Obstet Gynaecol Br Commonw 1973;180:469-472.
4. Bergqvist D, Burmark US, Flordal PA, Frisell J, Hallböök T, Hedberg M, Horn A, Kelty E, Kvitting P, Lindhagen A et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg 1995;82:496-501.
5. Bonnar J, Walsh J. Prevention of thrombosis after pelvic surgery by British Dextran 70. Lancet 1972;3:614-616.
6. Brummer THI, Jalkanen J, Fraser J, Heikkinen A, Kauko M, Mákinen J, Puistola U, Sjöberg J, Tomás E, Hárkki P. FINHYST 2006-national prospective 1-year survey of 5 279 hysterectomies. Hum Reprod 2009; 24:2515-2522.
7. Brummer T, Jalkanen J, Fraser J, Heikkinen A, Kauko M, Mákinen J, Seppála T, Sjöberg J, Eija Tomás E, Hárkki P. FINHYST, a prospective study of 5 279 hysterectomies: complications and their risk factors. Hum Reprod 2011;26:1741-1751.
8. Clarke-Pearson D, DeLong E, Synan I, Coleman R, CreasmanW. Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynaecology patients and creation of a prognostic model. Obstet Gynaecol 1987;69:146-150.
9. Einstein MH, Pritts EA, Hartenbach EM. Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review. Gynecol Oncol 2007;105:813-819.
10. Flordal PA, Berggvist D, Burmark US, Ljungström KG, Törngren S. Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations. The Fragmin Multicentre Study Group. Eur J Surg 1996;162:783-789.
11. Garry R, Fountain J, Mason S, Napp V, Brown J, Hawe J, Clayton R, Abbott J, Phillips G, Whittaker M et al. The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ 2004;328:129-136.
12. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB. Prevention of venous thromboembolism. Review. Chest 2001;119(1 Suppl.):132S-175S.
13. Geerts W, Bergqvist D, Pineo G, Heit J, Samama C, Lassen M, Colwell C., American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133(6 Suppl.):381S-453S.
14. Hager K, Setzer J, Vogl T, Platt D. Blood coagulation factors in the elderly. Arch Gerontol Geriatr 1989;9:277-282.
15. Hamilton P, Allardyce M, Ogston D, Dawson A, Douglas A. The effect of age upon the coagulation system. J Clin Pathol 1974; 27:980-982.
16. Hansen C, Kehlet H, Müler C, Mch L, Utzon J, Ottesen B. Timing of heparin prophylaxis and bleeding complications in hysterectomy: a nationwide prospective cohort study of 9 949 Danish women. Acta Obstet Gynecol Scand 2008;87:1039-1047.
17. Heinberg EM, Crawford BL, Weitzen SH, Bonilla DJ. Total laparoscopic hysterectomy in obese versus nonobese patients. Obstet Gynecol 2004;103:674-680.
18. Kakkar V, Corrigan T, Fossard D. Prevention of fatal postoperative pulmonary embolism by low doses of heparin: an international multicentre trial. Lancet 1975;12:45-51.
19. Kearon C. Natural history of venous tromboembolism. Circulation 2003; 107:I-22-I-30.
20. Löfgren M, Poromaa IS, Stjerndahl JH, Renström B,Postoperative infections and antibiotic prophylaxis for hysterectomy in Sweden: a study by the Swedish National Register for Gynecologic Surgery. Acta Obstet Gynecol Scand, 2004, 83, 1202-1207.
21. Mákinen J, Johansson J, Tomás C, Tomás E, Heinonen P, Laatikainen T, Kauko M, Heikkinen A, Sjöberg J. Morbidity of 10 110 hysterectomies by type approach. Hum Reprod 2001, 16, 1473-1478.
22. Mari D, Coppola R, Provenzano R. Mini review, hemostasis factors and ageing. Exp Gerontol 2008;43:66-73.
23. Maxwell GL, Synan I, Dodge R, Carroll B, Clarke-Pearson D. Pneumatic compresion versus low molecular weight heparin in gynaecologic oncology surgery: a randomized trial. Obstet Gynecol 2001;98: 989-995.
24. McPherson K, Metcalfe MA, Herbert A, Maresh M, Casbard A, Hargreaves J, Bridgman S, Clarke A. Severe complications of hysterectomy: the VALUE study. BJOG 2004;111:688-694.
25. Mismetti P, Laporte S, Darmon J, Buchmüller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001;88:913-930.
26. Moser K, Fedullo P, LittleJohn J, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 2004;271:223-225.
27. Osler M, Daugbjerg S, Frederiksen BL, Ottesen B. Body mass and risk of complications after hysterectomy on benign indications. Hum Reprod 2011;26:1512-1518.
28. Raskob GE, Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Review. Chest 2003;124(6 Suppl.):379S-385S.
29. Rasmussen K, Neumann G, Ljungström B, Hansen V, Lauszus F. The influence of body mass index on the prevalence of complications after vaginal and abdominal hysterectomy. Acta Obstet Gynecol Scand 2004; 83:85-88.
30. Rasmussen MS, Jgensen LN, Wille-Jgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Systemat Rev 2009, Art. No.: CD004318. DOI:10.1002/14651858.CD004318. pub2.
31. Ritch JM, Kim JH, Lewin SN, Burke WM, Sun X, Herzog TJ, Wright JD. Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy. Obstet Gynecol 2011; 117:1367-1374.
32. Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J of Clin Epid 2010;63:223-228.
33. Shapiro M, Muñoz A, Tager I, Schoenbaum S, Polk F. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Eng J Med 1982;307:1661-1666.
34. Spilsbury K, Semmens JB, Hammond I, Bolck A. Persistent high rates of hysterectomy in Western Australia: a population-based study of 83 000 procedures over 23 years. BJOG 2006;113:804-809.
35. Taberner D, Poller L, Burslem R, Jones J. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. BMJ 1978;1:272-274.
36. Turner G, Cole S, Brooks J. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecological surgery. Br J Obstet Gynaecol 1984;91:588-591.
37. Virtanen L, Harjola V, Hillbom M, Ahonen J, Kantola I, Rintala H, Lumio J, Kellokumpu I, Kankaanranta H, Hárkki P et al. Thromboprophylaxis in Finnish hospitals. Fin Med J 2010;15:1319-1326.
38. Walsh J, Bonnar J, Wright F. A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning. J Obstet Gynaecol Br Commonw 1974;81:311-316.
39. White R, Zhou H, Romano P. Incidence of symptomatic venous thromboembolims after different elective of urgent surgical procedures. Thromb Haemost 2003;90:446-455.